107 related articles for article (PubMed ID: 18401415)
1. STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma.
Ritz O; Guiter C; Dorsch K; Dusanter-Fourt I; Wegener S; Jouault H; Gaulard P; Castellano F; Möller P; Leroy K
Leukemia; 2008 Nov; 22(11):2106-10. PubMed ID: 18401415
[No Abstract] [Full Text] [Related]
2. Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.
Ritz O; Guiter C; Castellano F; Dorsch K; Melzner J; Jais JP; Dubois G; Gaulard P; Möller P; Leroy K
Blood; 2009 Aug; 114(6):1236-42. PubMed ID: 19423726
[TBL] [Abstract][Full Text] [Related]
3. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.
Melzner I; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Barth TF; Leithäuser F; Möller P
Blood; 2005 Mar; 105(6):2535-42. PubMed ID: 15572583
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of eotaxin expression by dexamethasone in normal human lung fibroblasts.
Suzuki T; Arakawa H; Mizuno T; Muramatsu K; Tadaki H; Takizawa T; Mochizuki H; Tokuyama K; Matsukura S; Morikawa A
Am J Respir Cell Mol Biol; 2008 Jun; 38(6):707-14. PubMed ID: 18203973
[TBL] [Abstract][Full Text] [Related]
5. [Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line].
Barth TF; Melzner I; Wegener S; Bucur AJ; Brüderlein S; Dorsch K; Hasel C; Leithäuser F; Möller P
Verh Dtsch Ges Pathol; 2005; 89():234-44. PubMed ID: 18035697
[TBL] [Abstract][Full Text] [Related]
6. Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
Natoli A; Lüpertz R; Merz C; Müller WW; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2013 Oct; 133(8):1945-54. PubMed ID: 23553437
[TBL] [Abstract][Full Text] [Related]
7. Differential IL-4/Stat6 activities correlate with differential expression of regulatory genes SOCS-1, SHP-1, and PP2A in colon cancer cells.
Yuan Q; Li PD; Li BH; Yang XZ; Xu SB; Liu XH; Zhou FX; Zhang WJ
J Cancer Res Clin Oncol; 2009 Jan; 135(1):131-40. PubMed ID: 18536936
[TBL] [Abstract][Full Text] [Related]
8. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
[TBL] [Abstract][Full Text] [Related]
9. STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma.
Miloudi H; Leroy K; Jardin F; Sola B
Cell Signal; 2018 Jun; 46():76-82. PubMed ID: 29501729
[TBL] [Abstract][Full Text] [Related]
10. [Unclassified B-cell lymphomas with "grey zone" characteristics].
Chen DB; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):278-81. PubMed ID: 21616011
[No Abstract] [Full Text] [Related]
11. Defective interleukin-4/Stat6 activity correlates with increased constitutive expression of negative regulators SOCS-3, SOCS-7, and CISH in colon cancer cells.
Liu XH; Xu SB; Yuan J; Li BH; Zhang Y; Yuan Q; Li PD; Li F; Zhang WJ
J Interferon Cytokine Res; 2009 Dec; 29(12):809-16. PubMed ID: 19929568
[TBL] [Abstract][Full Text] [Related]
12. Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells.
Kim MH; Kim MS; Kim W; Kang MA; Cacalano NA; Kang SB; Shin YJ; Jeong JH
PLoS One; 2015; 10(4):e0123133. PubMed ID: 25849377
[TBL] [Abstract][Full Text] [Related]
13. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.
Guiter C; Dusanter-Fourt I; Copie-Bergman C; Boulland ML; Le Gouvello S; Gaulard P; Leroy K; Castellano F
Blood; 2004 Jul; 104(2):543-9. PubMed ID: 15044251
[TBL] [Abstract][Full Text] [Related]
14. TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation
Burkhard R; Keller I; Arambasic M; Juskevicius D; Tzankov A; Lundberg P; Bruggmann R; Dirnhofer S; Radpour R; Novak U
Haematologica; 2019 Apr; 104(4):766-777. PubMed ID: 30381301
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling.
Dickensheets H; Vazquez N; Sheikh F; Gingras S; Murray PJ; Ryan JJ; Donnelly RP
Genes Immun; 2007 Jan; 8(1):21-7. PubMed ID: 17093501
[TBL] [Abstract][Full Text] [Related]
16. Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets.
Raia V; Schilling M; Böhm M; Hahn B; Kowarsch A; Raue A; Sticht C; Bohl S; Saile M; Möller P; Gretz N; Timmer J; Theis F; Lehmann WD; Lichter P; Klingmüller U
Cancer Res; 2011 Feb; 71(3):693-704. PubMed ID: 21127196
[TBL] [Abstract][Full Text] [Related]
17. Targeting STAT6 in PMBL.
Leroy K; Pujals A; Pelletier L
Oncotarget; 2014 Sep; 5(17):7216. PubMed ID: 25277174
[No Abstract] [Full Text] [Related]
18. STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL).
Ritz O; Rommel K; Dorsch K; Kelsch E; Melzner J; Buck M; Leroy K; Papadopoulou V; Wagner S; Marienfeld R; Brüderlein S; Lennerz JK; Möller P
Oncotarget; 2013 Jul; 4(7):1093-102. PubMed ID: 23852366
[TBL] [Abstract][Full Text] [Related]
19. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
20. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
Gualco G; Weiss LM; Barber GN; Bacchi CE
Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
